Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, J. S.
Right arrow Articles by Ornstein, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, J. S.
Right arrow Articles by Ornstein, D. K.
Clinical Cancer Research Vol. 8, 117-123, January 2002
© 2002 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Dysregulation of Annexin I Protein Expression in High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer1

John S. Kang, Benjamin F. Calvo, Susan J. Maygarden, Laura S. Caskey, James L. Mohler and David K. Ornstein2

Department of Surgery, Divisions of Urology [J. S. K., J. L. M., D. K. O.] and Surgical Oncology [B. F. C., L. S. C], Department of Pathology and Laboratory Medicine [S. J. M.], and Lineberger Comprehensive Cancer Center [B. F. C., S. J. M., L. S. C., J. L. M., D. K. O.], University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599

Purpose: To determine expression levels of annexin I (lipocortin I) in patient-matched benign prostatic epithelium (BPE), high-grade prostatic intraepithelial neoplasia (HGPIN), and prostate cancer (CaP).

Experimental Design: Annexin I protein expression was examined with a standard immunohistochemical protocol in 69 radical prostatectomy specimens, 45 of which also contained HGPIN. Immunostained sections were scored visually by a genitourinary pathologist and mean optical density was measured with digital image analysis. Real-time fluorescence quantitative PCR was used to measure expression levels of annexin I mRNA in patient-matched CaP and BPE from 14 snap-frozen, radical prostatectomy specimens.

Results: Annexin I protein expression was reduced in 91% (41/45) of HGPIN lesions and 94% (65/69) of invasive CaP compared with BPE in the same histological section when assessed visually. Mean absorbance was reduced significantly (P < 0.05) in 97.7% (44/45) of HGPIN lesions and 98.5% (68/69) of CaP glands compared with BPE. In 79% of cases (11/14; P < 0.05), mRNA expression was reduced in CaP as compared with patient-matched BPE. Annexin I mRNA and protein expression levels did not correlate with Gleason grade, pathological stage, or race.

Conclusions: Down-regulation of annexin I protein expression is a common finding in HGPIN and CaP, suggesting that annexin I dysregulation may be an important early event in CaP initiation. Because mRNA levels are reduced in a high proportion of cases, one likely mechanism for annexin I dysregulation occurs at the level of gene transcription. Results of these studies support a valuable role for a molecular profiling approach to CaP research.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J.-M. Mosquera, S. Perner, E. M. Genega, M. Sanda, M. D. Hofer, K. D. Mertz, P. L. Paris, J. Simko, T. A. Bismar, G. Ayala, et al.
Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications
Clin. Cancer Res., June 1, 2008; 14(11): 3380 - 3385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Sakaguchi, H. Murata, H. Sonegawa, Y. Sakaguchi, J.-i. Futami, M. Kitazoe, H. Yamada, and N.-h. Huh
Truncation of Annexin A1 Is a Regulatory Lever for Linking Epidermal Growth Factor Signaling with Cytosolic Phospholipase A2 in Normal and Malignant Squamous Epithelial Cells
J. Biol. Chem., December 7, 2007; 282(49): 35679 - 35686.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. H. K. Lim and S. Pervaiz
Annexin 1: the new face of an old molecule
FASEB J, April 1, 2007; 21(4): 968 - 975.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. L. Wang, T.-T. Wu, E. Resetkova, H. Wang, A. M. Correa, W. L. Hofstetter, S. G. Swisher, J. A. Ajani, A. Rashid, S. R. Hamilton, et al.
Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome
Clin. Cancer Res., August 1, 2006; 12(15): 4598 - 4604.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Garcia Pedrero, M. P. Fernandez, R. O. Morgan, A. Herrero Zapatero, M. V. Gonzalez, C. Suarez Nieto, and J. P. Rodrigo
Annexin A1 Down-Regulation in Head and Neck Cancer Is Associated with Epithelial Differentiation Status
Am. J. Pathol., January 1, 2004; 164(1): 73 - 79.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Watanabe, M. Ichihara, M. Hashimoto, K. Shimono, Y. Shimoyama, T. Nagasaka, Y. Murakumo, H. Murakami, H. Sugiura, H. Iwata, et al.
Characterization of Gene Expression Induced by RET with MEN2A or MEN2B Mutation
Am. J. Pathol., July 1, 2002; 161(1): 249 - 256.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.